Therapeutic hypoxia to protect and revive ischemic heart and brain

Mil Med Res. 2026;13(1):100064. doi: 10.1016/j.mmr.2026.100064. Epub 2026 Aug 19.ABSTRACTAlthough hypoxia plays a central role in the pathobiology of cardiovascular and cerebrovascular diseases, controlled hypoxic stimuli, such as intermittent hypoxia conditioning (IHC), can trigger beneficial adapt

J Johannes Burtscher

Association of one-hour postload plasma glucose combined with metabolic dysfunction-associated steatotic liver disease and FIB-4 screening positivity with elevated LDL cholesterol and cerebrovascular stenosis

Front Endocrinol (Lausanne). 2026 Aug 14;17:1887611. doi: 10.3389/fendo.2026.1887611. eCollection 2026.ABSTRACTBACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in type 2 diabetes mellitus (T2DM) and amplifies cardiovascular and metabolic burden. Elevat

F Fengtong Zuo

Risk of Heart Failure Hospitalization Associated With Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis-Stimulating Agents: A Nationwide Claims-Based Cohort Study

Pharmacoepidemiol Drug Saf. 2026 Sep;35(9):e70453. doi: 10.1002/pds.70453.ABSTRACTPURPOSE: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are increasingly used to treat renal anemia in patients with chronic kidney disease (CKD). We evaluated the risk of heart failure associated wi

Y Yuki Kunitsu

Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults

NEJM Evid. 2026 Aug 29:EVIDoa2600272. doi: 10.1056/EVIDoa2600272. Online ahead of print.ABSTRACTBACKGROUND: Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The

M Mats C Lassen

Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons

NEJM Evid. 2026 Aug 29:EVIDoa2600242. doi: 10.1056/EVIDoa2600242. Online ahead of print.ABSTRACTBACKGROUND: Respiratory syncytial virus (RSV) is an important cause of hospitalization and death among older adults. Although first-season vaccine effectiveness against RSV-related hospitalization has bee

M Mats C Højbjerg Lassen

Venous thromboembolism in 5-year cancer survivors: a nationwide cohort study

Eur J Prev Cardiol. 2026 Aug 29:zwag439. doi: 10.1093/eurjpc/zwag439. Online ahead of print.ABSTRACTAIMS: Cancer is associated with a significant short-term risk of venous thromboembolism (VTE). With substantial improvements in cancer survival, concern has been raised about an increased risk of VTE

A Adelina Yafasova

Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial

Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082511. Online ahead of print.ABSTRACTBACKGROUND: Hypertension is the leading risk factor for cardiovascular disease (CVD) worldwide. Implementation-based blood pressure (BP) control programs improve BP control and reduce CVD risk, but whethe

G Guozhe Sun